Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca looks to DNA damage-response drugs for edge in oncology
AstraZeneca looks to DNA damage-response drugs for edge in oncology
AstraZeneca looks to DNA damage-response drugs for edge in oncology
Submitted by
admin
on May 17, 2016 - 9:25am
Source:
BioPharma Dive
News Tags:
AstraZeneca
oncology
ASCO
Lynparza
Headline:
AstraZeneca looks to DNA damage-response drugs for edge in oncology
Do Not Allow Advertisers to Use My Personal information
